biospecimen__admin__batch_number	131.77.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	23333242-369A-41B0-9D34-3ED88E1CB237
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-DD-A1EL-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-DD-A1EL-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-DD-A1EL-01A
biospecimen__bio__biospecimen_barcode_bottom	0099052765
biospecimen__bio__day_of_creation	31
biospecimen__bio__day_of_shipment	10
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	01
biospecimen__bio__month_of_shipment	05
biospecimen__bio__pathology_report_file_name	TCGA-DD-A1EL.C8A1098A-0717-4801-A3E5-C13C42C65936.pdf
biospecimen__bio__plate_column	6
biospecimen__bio__plate_id	A154
biospecimen__bio__plate_row	B
biospecimen__bio__portion_sequence	1
biospecimen__bio__quantity	3.60
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2011
biospecimen__bio__year_of_shipment	2011
biospecimen__shared__bcr_patient_barcode	TCGA-DD-A1EL
biospecimen__shared__patient_id	A1EL
clinical__ablation__ablation_performed_indicator	NO
clinical__ablation__bcr_ablation_barcode	TCGA-DD-A1EL-A42231
clinical__ablation__bcr_ablation_uuid	6CA54E88-D6C5-4F67-B456-159E16441697
clinical__ablation__days_to_embolization_performed	165
clinical__ablation__embolization_performed_indicator	YES
clinical__ablation__embolization_type	Chemoembolization
clinical__ablation__embolizing_agent_utilized	Other, specify
clinical__ablation__embolizing_agent_utilized_other	PVA particles
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	6BC23F99-BC34-4443-A66B-0826F6F95D07
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.5
clinical__chol_lihc_shared__albumin_result_specified_value	4.4
clinical__chol_lihc_shared__albumin_result_upper_limit	5.0
clinical__chol_lihc_shared__bilirubin_lower_limit	0.1
clinical__chol_lihc_shared__bilirubin_upper_limit	0.5
clinical__chol_lihc_shared__child_pugh_classification_grade	A
clinical__chol_lihc_shared__creatinine_lower_level	0.8
clinical__chol_lihc_shared__creatinine_upper_limit	1.3
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	1.0
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	6
clinical__chol_lihc_shared__fetoprotein_outcome_value	5
clinical__chol_lihc_shared__fibrosis_ishak_score	0 - No Fibrosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis B
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	8.3
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	10.8
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	450
clinical__chol_lihc_shared__prothrombin_time_result_value	10.8
clinical__chol_lihc_shared__specimen_collection_method_name	Segmentectomy, Multiple
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.0
clinical__chol_lihc_shared__vascular_tumor_cell_type	None
clinical__clin_shared__age_at_initial_pathologic_diagnosis	23
clinical__clin_shared__bcr_followup_barcode	TCGA-DD-A1EL-F42229
clinical__clin_shared__bcr_followup_uuid	307DC566-5815-4352-96AB-67938D531924
clinical__clin_shared__day_of_form_completion	15
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	0
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	5
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	153
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__relative_family_cancer_history	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	NO
clinical__clin_shared__tissue_retrospective_collection_indicator	YES
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis B Surface Antigen
clinical__clin_shared__year_of_form_completion	2013
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2009
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Mild
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	Yes
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	NO
clinical__nte__additional_radiation_therapy	NO
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Intrahepatic Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T2
clinical__shared_stage__system_version	6th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	43c64cc8-3f45-4742-9abd-9bcfdc6d76b5
gdc__aliquots__concentration	0.18
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-DD-A1EL-01A-11R-A154-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	1a8e8060-8b94-4db7-ad5b-7b9d7a80fe01
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.87
gdc__analytes__analyte_id	c392bedd-0c98-4bbe-9201-66a91f2ecf0a
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	2854ffe8-1f77-497a-bf49-11e0189fee35
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:44:50.676868-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	618089d3-91c9-5efa-b785-80cfbeecedae
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	black or african american
gdc__demographic__year_of_birth	1986
gdc__demographic__year_of_death	2010
gdc__diagnoses__age_at_diagnosis	8573
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-8573.0
gdc__diagnoses__days_to_death	415.0
gdc__diagnoses__diagnosis_id	9e5fdaec-867f-5e80-9abb-f0993ef1ceb7
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage ii
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	16.302378939741576
gdc__exposures__exposure_id	260938b3-0c46-569d-a868-9b893064f0c7
gdc__exposures__height	182.0
gdc__exposures__weight	54.0
gdc__file_id	4c8c3be7-afac-4ab7-b80d-026943410277
gdc__file_name	c9ed9784-8393-4df6-8f37-a5be03669c3d.mirbase21.mirnas.quantification.txt
gdc__file_size	50310
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	2ea34b70cb8c967f2b8b9cf6d8e14bbc
gdc__portions__is_ffpe	false
gdc__portions__portion_id	22b395d6-60ee-4337-8566-d6751b0eaf9f
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	577
gdc__samples__initial_weight	130.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	C8A1098A-0717-4801-A3E5-C13C42C65936
gdc__samples__sample_id	5a756b40-6c08-47e8-9b25-9b3ffff39606
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	3.0
gdc__slides__percent_monocyte_infiltration	0.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	0.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	10.0
gdc__slides__percent_tumor_cells	90.0
gdc__slides__percent_tumor_nuclei	90.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	07c76cbd-9d5a-4535-94af-8d412b60de75
gdc__submitter_id	mirna_swap_dr11_316_MirnaExpression33da6aad-0d0c-4e0d-8c79-209db82e10c9_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	DD
gdc__tissue_source_site__name	Mayo Clinic - Rochester
gdc__tissue_source_site__tissue_source_site_id	c2eb5c30-93cc-5a99-b9e4-f676e35ed7f8
gdc__treatments__treatment_id	37b16fdb-a34c-5118-a19a-2e7aaee0a907
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:08:05.258+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/43c64cc8-3f45-4742-9abd-9bcfdc6d76b5-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/43c64cc8-3f45-4742-9abd-9bcfdc6d76b5-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129681
manually_curated__local_md5	b53341446533968d55336374a4f64edf
manually_curated__opengdc_download_date	2018-10-16T17:10:52.000777+02:00
manually_curated__opengdc_file_md5	c8e2ce93775c83719c766de9f213d3a7
manually_curated__opengdc_file_size	50309
manually_curated__opengdc_id	43c64cc8-3f45-4742-9abd-9bcfdc6d76b5-meq
manually_curated__origin_file_size	129681
manually_curated__origin_last_modified_date	Tue Oct 16 18:02:00 CEST 2018
manually_curated__origin_md5	b53341446533968d55336374a4f64edf
manually_curated__tissue_status	tumoral
